AB Science S.A. (ABSCF)
OTCMKTS
· Delayed Price · Currency is USD
1.260
-0.340 (-21.25%)
At close: Jun 6, 2025
AB Science Revenue
In the year 2024, AB Science had annual revenue of 1.07M EUR with 10.52% growth. AB Science had revenue of 512.00K in the half year ending December 31, 2024, with 55.62% growth.
Revenue
1.07M EUR
Revenue Growth
+10.52%
P/S Ratio
113.65
Revenue / Employee
27.49K EUR
Employees
39
Market Cap
126.13M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.07M | 102.00K | 10.52% |
Dec 31, 2023 | 970.00K | 12.00K | 1.25% |
Dec 31, 2022 | 958.00K | -649.00K | -40.39% |
Dec 31, 2021 | 1.61M | 24.00K | 1.52% |
Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 84.04M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |